STOCK TITAN

[Form 4] Penumbra Inc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Pursuant to a Form 4, Penumbra Inc. director and officer Shruthi Narayan was granted 9,170 restricted stock units (RSUs) on 09/15/2025 under the companys Amended and Restated 2014 Equity Incentive Plan. The RSUs vest 25% on each annual anniversary beginning 09/15/2026, subject to continued service. Following the grant, the reporting persons beneficial ownership is reported as 28,255 shares, with a portion of those shares subject to vesting.

In conformità a una Form 4, Shruthi Narayan, direttrice e dirigente di Penumbra Inc., è stata assegnata 9.170 unità di azioni vincolate (RSU) il 15/09/2025 ai sensi del Piano di Incentivi Azionari del 2014, come emendato e integrato della società. Le RSU vestono al 25% ad ogni anniversario annuale a partire dal 15/09/2026, subordinatamente al mantenimento del servizio. Dopo l’assegnazione, la proprietà beneficiaria della persona reportante è riportata come 28.255 azioni, con una parte di tali azioni soggetta a vesting.

De conformidad con un Formulario 4, Shruthi Narayan, directora y ejecutiva de Penumbra Inc., recibió 9.170 unidades de acciones restringidas (RSU) el 15/09/2025 bajo el Plan de Incentivos de Acciones de 2014, enmendado y reformulado de la empresa. Las RSU se consolidan al 25% en cada aniversario anual a partir del 15/09/2026, sujeto a la continuidad del servicio. Después de la concesión, la titularidad beneficiaria de la persona informante se reporta como 28.255 acciones, con una parte de esas acciones sujeta a vesting.

Form 4에 따라 Penumbra Inc. 이사이자 임원인 Shruthi Narayan은 2025년 9월 15일 회사의 2014년 주식매수제한단계(RSU)로 9,170주식매수제한단위을 부여받았습니다. 이 RSU는 2026년 9월 15일부터 매년 기념일마다 25%씩 vest되며, 계속 근무가 조건입니다. 부여 후 보고자의 지분은 28,255주로 보고되며, 그 중 일부 주식은 vesting 대상입니다.

Conformément à un Form 4, Shruthi Narayan, administratrice et dirigeante de Penumbra Inc., a reçu 9 170 unités d’actions restreintes (RSU) le 15/09/2025 dans le cadre du Plan d’incitation en actions de 2014, tel que modifié et reconduit par la société. Les RSU se vestent à 25 % à chaque anniversaire annuel à partir du 15/09/2026, sous réserve de la poursuite du service. Après l’octroi, la propriété bénéficiaire de la personne déclarée est déclarée comme 28 255 actions, une partie de ces actions étant soumise à vesting.

In Übereinstimmung mit einem Formblatt 4 erhielt Shruthi Narayan, Direktorin und Beamtin von Penumbra Inc., am 15.09.2025 9.170 Restricted Stock Units (RSUs) gemäß dem amendierten und neu formulierten Equity-Incentive-Plan von 2014 der Gesellschaft. Die RSUs vesten zu 25% bei jedem jährlichen Jahrestag beginnend am 15.09.2026, vorbehaltlich fortdauernder Diensterfüllung. Nach der Zuteilung wird das wirtschaftliche Eigentum der meldenden Person als 28.255 Aktien angegeben, wobei ein Teil dieser Aktien dem Vesting unterliegt.

وفقاً للنموذج 4، تلقت Shruthi Narayan، المديرة التنفيذية ونائبة رئيس شركة Penumbra Inc., 9,170 وحدة أسهم مقيدة (RSU) في 15/09/2025 بموجب خطة التحفيز بالأسهم لعام 2014 كما عدلت وبُدلت من قبل الشركة. تتحقق RSUs بنسبة 25% في كل ذكرى سنوية ابتداءً من 15/09/2026، رهناً باستمرار الخدمة. عقب المنحة، يتم الإبلاغ عن الملكية المفيدة للشخص المبلغ عنها كـ 28,255 سهمًا، مع جزء من تلك الأسهم خاضع لعملية الاستحقاق.

根据 Form 4,Penumbra Inc. 的董事兼高管 Shruthi Narayan 于 2025/09/15 根据公司修订并重新制定的 2014 股权激励计划获得了 9,170 份受限股票单位(RSU)。这些 RSU 将在首次 2026/09/15 开始的每个年度纪年日按 25% 归属,前提是继续任职。授予后,申报人持有的实际控制权为 28,255 股,其中部分股权处于归属阶段。

Positive
  • 9,170 RSUs granted to the reporting person on 09/15/2025
  • Clear vesting schedule: 25% vests annually beginning 09/15/2026
  • Post-transaction beneficial ownership disclosed: 28,255 shares
Negative
  • None.

Insights

TL;DR: Insider received 9,170 RSUs; ownership now 28,255 shares, standard time-based vesting over four years.

The grant of 9,170 RSUs is a routine equity compensation event for an officer and director, creating potential future dilution when vested shares settle. The award vests 25% annually beginning one year after grant, which aligns compensation with continued service. The Form 4 shows the post-transaction beneficial ownership of 28,255 shares, but does not disclose exercise prices or settled share counts for prior awards. Overall, this is a standard disclosure without indications of unusual trading or immediate cash proceeds.

TL;DR: Time-based RSU grant with four-year vesting; disclosure appears complete and routine under Section 16 reporting.

The filing documents a standard grant under the companys 2014 Equity Incentive Plan with a clear vesting schedule (1/4 annually). The Form 4 is signed by an attorney-in-fact and reports ownership changes consistent with compensation practices for officers who also serve as directors. The filing does not indicate performance-based conditions or accelerated vesting, nor does it show any derivative transactions. As provided, the disclosure is straightforward and meets reporting requirements.

In conformità a una Form 4, Shruthi Narayan, direttrice e dirigente di Penumbra Inc., è stata assegnata 9.170 unità di azioni vincolate (RSU) il 15/09/2025 ai sensi del Piano di Incentivi Azionari del 2014, come emendato e integrato della società. Le RSU vestono al 25% ad ogni anniversario annuale a partire dal 15/09/2026, subordinatamente al mantenimento del servizio. Dopo l’assegnazione, la proprietà beneficiaria della persona reportante è riportata come 28.255 azioni, con una parte di tali azioni soggetta a vesting.

De conformidad con un Formulario 4, Shruthi Narayan, directora y ejecutiva de Penumbra Inc., recibió 9.170 unidades de acciones restringidas (RSU) el 15/09/2025 bajo el Plan de Incentivos de Acciones de 2014, enmendado y reformulado de la empresa. Las RSU se consolidan al 25% en cada aniversario anual a partir del 15/09/2026, sujeto a la continuidad del servicio. Después de la concesión, la titularidad beneficiaria de la persona informante se reporta como 28.255 acciones, con una parte de esas acciones sujeta a vesting.

Form 4에 따라 Penumbra Inc. 이사이자 임원인 Shruthi Narayan은 2025년 9월 15일 회사의 2014년 주식매수제한단계(RSU)로 9,170주식매수제한단위을 부여받았습니다. 이 RSU는 2026년 9월 15일부터 매년 기념일마다 25%씩 vest되며, 계속 근무가 조건입니다. 부여 후 보고자의 지분은 28,255주로 보고되며, 그 중 일부 주식은 vesting 대상입니다.

Conformément à un Form 4, Shruthi Narayan, administratrice et dirigeante de Penumbra Inc., a reçu 9 170 unités d’actions restreintes (RSU) le 15/09/2025 dans le cadre du Plan d’incitation en actions de 2014, tel que modifié et reconduit par la société. Les RSU se vestent à 25 % à chaque anniversaire annuel à partir du 15/09/2026, sous réserve de la poursuite du service. Après l’octroi, la propriété bénéficiaire de la personne déclarée est déclarée comme 28 255 actions, une partie de ces actions étant soumise à vesting.

In Übereinstimmung mit einem Formblatt 4 erhielt Shruthi Narayan, Direktorin und Beamtin von Penumbra Inc., am 15.09.2025 9.170 Restricted Stock Units (RSUs) gemäß dem amendierten und neu formulierten Equity-Incentive-Plan von 2014 der Gesellschaft. Die RSUs vesten zu 25% bei jedem jährlichen Jahrestag beginnend am 15.09.2026, vorbehaltlich fortdauernder Diensterfüllung. Nach der Zuteilung wird das wirtschaftliche Eigentum der meldenden Person als 28.255 Aktien angegeben, wobei ein Teil dieser Aktien dem Vesting unterliegt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Narayan Shruthi

(Last) (First) (Middle)
ONE PENUMBRA PLACE

(Street)
ALAMEDA CA 94502

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Penumbra Inc [ PEN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President
3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/15/2025 A 9,170(1) A $0 28,255(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. On September 15, 2025, the Reporting Person was granted 9,170 restricted stock units (RSUs) under the Issuer's Amended and Restated 2014 Equity Incentive Plan, of which 1/4 of the RSUs will vest equally on an annual basis, beginning on September 15, 2026, subject to continued service by the Reporting Person on the applicable vesting date.
2. A portion of these shares is subject to vesting.
Remarks:
/s/ Johanna Roberts, as attorney-in-fact for Shruthi Narayan 09/16/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Form 4 for PEN disclose about Shruthi Narayans transaction?

The Form 4 discloses a grant of 9,170 RSUs on 09/15/2025 and a reported beneficial ownership of 28,255 shares after the transaction.

When do the RSUs granted to Shruthi Narayan begin to vest?

The RSUs vest 25% annually, with the first tranche vesting on 09/15/2026, subject to continued service.

Are the RSUs immediately exercisable or subject to conditions?

The RSUs are subject to time-based vesting; a portion is unvested and will vest over the next three years after the first anniversary.

Does the Form 4 show any derivative transactions or sales by Shruthi Narayan?

No. The filing reports a non-derivative grant of RSUs and does not disclose any derivative transactions, dispositions, or cash proceeds.
Penumbra Inc

NYSE:PEN

PEN Rankings

PEN Latest News

PEN Latest SEC Filings

PEN Stock Data

10.00B
37.54M
3.66%
93.38%
4.59%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ALAMEDA